Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Esmail D, Zanjani"'
Autor:
Zanjani ED
Publikováno v:
Journal of hematotherapy & stem cell research [J Hematother Stem Cell Res] 2000 Apr; Vol. 9 (2), pp. 129-32.
Autor:
Saloomeh Mokhtari, Evan J. Colletti, Anthony Atala, Esmail D. Zanjani, Christopher D. Porada, Graça Almeida-Porada
Publikováno v:
Stem Cell Reports, Vol 6, Iss 6, Pp 957-969 (2016)
Summary: In utero hematopoietic stem/progenitor cell transplantation (IUHSCT) has only been fully successful in the treatment of congenital immunodeficiency diseases. Using sheep as a large animal model of IUHSCT, we demonstrate that administration o
Externí odkaz:
https://doaj.org/article/b21d775a538c4be5abafacd34ba043b8
Autor:
Melisa A Soland, Mariana Bego, Evan Colletti, Esmail D Zanjani, Stephen St Jeor, Christopher D Porada, Graça Almeida-Porada
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e60461 (2013)
Mesenchymal stem cells (MSC) preferentially migrate to damaged tissues and, due to their immunomodulatory and trophic properties, contribute to tissue repair. Although MSC express molecules, such as membrane cofactor protein (CD46), complement decay-
Externí odkaz:
https://doaj.org/article/f02c20f57026471eab3a1aeab57c23fb
Autor:
Melisa A Soland, Mariana G Bego, Evan Colletti, Christopher D Porada, Esmail D Zanjani, Stephen St Jeor, Graça Almeida-Porada
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36163 (2012)
Mesenchymal stem cells (MSC) are promising candidates for cell therapy, as they migrate to areas of injury, differentiate into a broad range of specialized cells, and have immunomodulatory properties. However, MSC are not invisible to the recipient's
Externí odkaz:
https://doaj.org/article/574d0e45e47c40da8511fbde23877dd3
Autor:
Steven Walker, Weihong Yin, Anthony Atala, Graça Almeida-Porada, Christopher D. Porada, Evan Colletti, Chad Sanada, Esmail D. Zanjani, Saloomeh Mokhtari, Colin E. Bishop, Paul J. Simmons, Zanetta S. Lamar
Publikováno v:
Leukemia
The presence, within the human bone marrow, of cells with both endothelial and hemogenic potential has been controversial. Herein, we identify, within the human fetal bone marrow, prior to establishment of hematopoiesis, a unique APLNR+, Stro-1+ cell
Publikováno v:
Fetal Stem Cells in Regenerative Medicine ISBN: 9781493934812
During the last few decades, the human fetus has become a candidate for therapeutic interventions; however, most of these therapies are surgical in nature and target specific anatomic defects that benefit from prenatal intervention. In this chapter w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fef3db21b5af87e7bbe74f589bab3a2
https://doi.org/10.1007/978-1-4939-3483-6_17
https://doi.org/10.1007/978-1-4939-3483-6_17
Autor:
Steven Walker, Graça Almeida-Porada, Weihong Yin, Paul J. Simmons, Esmail D. Zanjani, Christopher D. Porada, Anthony Atala, Zanetta S. Lamar, Colin E. Bishop, Evan Colletti, Saloomeh Mokhtari, Chad Sanada
Publikováno v:
Leukemia. 32:1670-1670
At the time of publication the funding information was omitted from the article – this has now been corrected in both the HTML and the PDF.
Autor:
David Thain, Esmail D. Zanjani, Adel Ersek, A. Daisy Goodrich, Graça Almeida-Porada, John S. Pixley, Christopher D. Porada
Publikováno v:
Experimental Hematology. 38:311-320
Objective To determine if mesenchymal stem cells (MSC) derived from human fetal pancreatic tissue (pMSC) would engraft and differentiate in sheep pancreas following transplantation in utero. Materials and Methods A three-step culture system was estab
Autor:
Joao L. Ascensao, Christopher D. Porada, Cláudia Lobato da Silva, Joaquim M. S. Cabral, Graça Almeida-Porada, Raquel Gonçalves, Esmail D. Zanjani
Publikováno v:
Journal of Cellular Physiology. 220:102-111
Human hematopoietic stem/progenitor cells (HSC) isolated based upon specific patterns of CD34 and CD38 expression, despite phenotypically identical, were found to be functionally heterogeneous, raising the possibility that reversible expression of th
Autor:
Christopher D. Porada, Takashi Yamagami, Esmail D. Zanjani, Graça Almeida-Porada, Ronald Pardini
Publikováno v:
Cancer Biology & Therapy. 8:331-337
Acute myeloid leukemia (AML) is the most frequently diagnosed adulthood leukemia, yet current therapies offer a cure rate of less than 30%. This may be due in part to the fact that the leukemia-initiating cells in AML reside within the rare and highl